Contamination with HIV antibody may be responsible for false positive results in specimens tested on automated platforms running HIV 4th generation assays in a region of high HIV prevalence

Abstract

IntroductionIn South Africa where the prevalence of HIV infection is very high, 4th generation HIV antibody/p24 antigen combo immunoassays are the tests of choice for laboratory based screening. Testing is usually performed in clinical pathology laboratories on automated analysers. To investigate the cause of false positive results on 4th generation HIV testing platforms in public sector laboratories, the performance of two automated platforms was compared in a clinical pathology setting, firstly on routine diagnostic specimens and secondly on known sero-negative samples.MethodsFirstly, 1181 routine diagnostic specimens were sequentially tested on Siemens and Roche automated 4th generation platforms. HIV viral load, western blot and follow up testing were used to determine the true status of inconclusive specimens. Subsequently, known HIV seronegative samples from a single donor were repeatedly tested on both platforms and an analyser was tested for surface contamination with HIV positive serum to identify how suspected specimen contamination could be occurring.ResultsSerial testing of diagnostic specimens yielded 163 weakly positive or discordant results. Only 3 of 163 were conclusively shown to indicate true HIV infection. Specimen contamination with HIV antibody was suspected, based on the following evidence: the proportion of positive specimens increased on repeated passage through the analysers; viral loads were low or undetectable and western blots negative or indeterminate on problem specimens; screen negative, 2nd test positive specimens tested positive when reanalysed on the screening assay; follow up specimens (where available) were negative. Similarly, an increasing number of known negative specimens became (repeatedly) sero-positive on serial passage through one of the analysers. Internal and external analyser surfaces were contaminated with HIV serum, evidence that sample splashes occur during testing.ConclusionsDue to the extreme sensitivity of these assays, contamination with minute amounts of HIV antibody can cause a negative sample to test positive. Better contamination control measures are needed on analysers used in clinical pathology environments, especially in regions where HIV sero-prevalence is high.

HIV false positive screening serology due to sample contamination reduced by a dedicated sample and platform in a high prevalence environment

“…FP results usually generate LP&E S/CO signals as seen by other centres [ 2 , 6 , 7 ]. Using a combination of independent sample testing and different platform testing, for confirmation, we found that 85% of LP&E results were FP and therefore, LP&E result prevalence can be used as an indicator of FP rate.…”

“…In a high prevalence setting, prior research by Hardie et al (2017) found that repeatedly processing known HIV negative samples through automated platforms increased the probability of the sample subsequently testing positive [ 2 ]. A similar platform and setting exist at TBH NHLS where the Roche® Modular Pre-Analytic System (MPA) is used to process samples received for Clinical Chemistry, Immunology and Virology.…”

The use of the GeeniusTM HIV‐1/2 Rapid confirmatory test for the enrolment of patients and blood donors in the WHO Universal Test and Treat Strategy in Cameroon, Africa

“…Considering the potential consequences of false-positive or discordant results on blood shortage and clinical management of donors since a misdiagnosis may lead to inappropriate treatments, measures should be taken to avoid or at least limit them [30,31]. Alongside well-performed laboratory testing, implementing an efficient quality system that includes organizational management, quality standards, traceability, equipment qualification, reagent verification before use, regular staff training and participation to proficiency studies may improve the performance of the screening test.…”

HIV-1 RNA testing of pooled dried blood spots is feasible to diagnose acute HIV infection in resource limited settings

“…Fourth generation HIV laboratory based tests are more sensitive than third generation rapid tests, but have other problems such as increased turnaround time (resulting in possible delays in treatment and loss to follow up) and particular automated assays may be prone to sample contamination. 28 Most fourth generation HIV serology platforms are also not validated for testing with DBS, but some studies have shown promise. 31 Given that the DBS technique is currently the only means of sample transport over long distances and without the need for cold storage, it will be important for manufacturers of laboratory-based tests to validate their platforms for use with DBS.…”